Log In
Print
BCIQ
Print
Print this Print this
 

CJ-12420, RQ-00000004

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionCompetitive acid pump antagonist that inhibits binding of potassium ion to H+/K ATPase
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat erosive esophagitis; Treat gastroesophageal reflux disease (GERD)
Regulatory Designation

Partner

CJ Group


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today